YSPSAH-7178

Y.S.P.SOUTHEAST ASIA HOLDING BERHAD

Last Price: 2.4

TTM Dividend Yield : 3.33%

Coming Quarter Report: ~ 2020-11-19

Yahoo Google Bursa Web TradingView

Sector: Pharmaceuticals

Y.S.P. Southeast Asia Holding Berhad is engaged in investment holding and provision of management services. The Company operates in three segments: Trading, which is engaged in import, export and trading in various kinds of pharmaceutical, traditional herbal and veterinary products; Manufacturing, which is engaged in manufacturing of pharmaceutical products, and investment holding, which is engaged in investment holding. Its subsidiaries include Y.S.P. SAH (Vietnam) Co., Ltd. and Y.S.P. SAH Investment Pte. Ltd., which are engaged in investment holding; Y.S.P. Industries (M) Sdn. Bhd., which is the importer, exporter and manufacturer of pharmaceuticals and veterinary products, pharmaceutical fine chemicals and provision of management services, and PT. Yung Shin Pharmaceutical Indonesia, which is engaged in trading in various kinds of pharmaceutical products.

**Do feedback to us if you see any error on the data

Dividend

YSPSAH Dividend Yield Trend

YSPSAH Quarter DY Yield

YSPSAH Annual DY Yield

Profit

YSPSAH Quarter Report History

YSPSAH Quarter Profit Trend

YSPSAH Annual Profit Trend

Cash Flow

Cash Flow

In financial accounting, operating cash flow (OCF), cash flow provided by operations, cash flow from operating activities (CFO) or free cash flow from operations (FCFO), refers to the amount of cash a company generates from the  revenues it brings in, excluding  costs associated with long – term  investment  on capital items or investment in securities.(From Wiki)

YSPSAH Annual Cash Flow



			

0 Comments

  1. Y.S.P. Southeast Asia Holding Bhd is an investment company, which engages in the pharmaceutical business, provision of management services. It operates through the following segments: Trading, Manufacturing and Investment Holding. The Trading segment imports, exports, and trades various kinds of pharmaceutical products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. Firm’s majority revenue comes from the Manufacturing segment. Its majority revenue is concentrated in Malaysia.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *